These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 19416095)

  • 21. Effects of pilocarpine and cevimeline on Ca2+ mobilization in rat parotid acini and ducts.
    Ono K; Inagaki T; Iida T; Hosokawa R; Inenaga K
    J Med Invest; 2009; 56 Suppl():375. PubMed ID: 20224229
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of cevimeline on salivary components in patients with Sjögren syndrome.
    Suzuki K; Matsumoto M; Nakashima M; Takada K; Nakanishi T; Okada M; Ohsuzu F
    Pharmacology; 2005 May; 74(2):100-5. PubMed ID: 15722648
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decreased salivary flow rate as a dipsogenic factor in hemodialysis patients: evidence from an observational study and a pilocarpine clinical trial.
    Sung JM; Kuo SC; Guo HR; Chuang SF; Lee SY; Huang JJ
    J Am Soc Nephrol; 2005 Nov; 16(11):3418-29. PubMed ID: 16177001
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tramadol-induced oral dryness and pilocarpine treatment: effects on total protein and IgA.
    Looström H; Akerman S; Ericson D; Tobin G; Götrick B
    Arch Oral Biol; 2011 Apr; 56(4):395-400. PubMed ID: 21112044
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional relationship between subfornical organ cholinergic stimulation and nitrergic activation influencing cardiovascular and body fluid homeostasis.
    Saad WA; Guarda IF; Camargo LA; dos Santos TA; Saad WA
    Regul Pept; 2007 Oct; 143(1-3):28-33. PubMed ID: 17395280
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlation between salivary secretion and salivary AQP5 levels in health and disease.
    Wang D; Iwata F; Muraguchi M; Ooga K; Ohmoto Y; Takai M; Mori T; Ishikawa Y
    J Med Invest; 2009; 56 Suppl():350-3. PubMed ID: 20224222
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapeutic effect of cevimeline on dry eye in patients with Sjögren's syndrome: a randomized, double-blind clinical study.
    Ono M; Takamura E; Shinozaki K; Tsumura T; Hamano T; Yagi Y; Tsubota K
    Am J Ophthalmol; 2004 Jul; 138(1):6-17. PubMed ID: 15234277
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pilocarpine for the treatment of salivary glands' impairment caused by radioiodine therapy for thyroid cancer.
    Aframian DJ; Helcer M; Livni D; Markitziu A
    Oral Dis; 2006 May; 12(3):297-300. PubMed ID: 16700739
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of the discontinuation rates and side-effect profiles of pilocarpine and cevimeline for xerostomia in primary Sjögren's syndrome.
    Noaiseh G; Baker JF; Vivino FB
    Clin Exp Rheumatol; 2014; 32(4):575-7. PubMed ID: 25065774
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutans streptococci in xerostomic cancer patients after pilocarpine therapy: a pilot study.
    Chambers MS; Keene HJ; Toth BB; Lemon JC; Gallagher SC; Martin CG; Martin JW
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2005 Feb; 99(2):180-4. PubMed ID: 15660089
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Damage of the medial preoptic area impairs peripheral pilocarpine-induced salivary secretion.
    Lopes de Almeida R; De Luca LA; de Almeida Colombari DS; Menani JV; Renzi A
    Brain Res; 2006 Apr; 1085(1):144-8. PubMed ID: 16580646
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of pilocarpine-induced saliva secretion by adrenergic agonists in ICR mice.
    Imamura TK; Yoshino Y; Yamachika S; Ishii H; Watanabe NY; Inoue H; Nakagawa Y
    Clin Exp Pharmacol Physiol; 2012 Dec; 39(12):1038-43. PubMed ID: 23075092
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of cevimeline on excitability of parasympathetic preganglionic neurons in the superior salivatory nucleus of rats.
    Mitoh Y; Ueda H; Ichikawa H; Fujita M; Kobashi M; Matsuo R
    Auton Neurosci; 2017 Sep; 206():1-7. PubMed ID: 28600120
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Open-label, long-term safety study of cevimeline in the treatment of postirradiation xerostomia.
    Chambers MS; Jones CU; Biel MA; Weber RS; Hodge KM; Chen Y; Holland JM; Ship JA; Vitti R; Armstrong I; Garden AS; Haddad R
    Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1369-76. PubMed ID: 17855005
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cevimeline for the treatment of postirradiation xerostomia in patients with head and neck cancer.
    Chambers MS; Posner M; Jones CU; Biel MA; Hodge KM; Vitti R; Armstrong I; Yen C; Weber RS
    Int J Radiat Oncol Biol Phys; 2007 Jul; 68(4):1102-9. PubMed ID: 17379432
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Current therapies for xerostomia and salivary gland hypofunction associated with cancer therapies.
    Nieuw Amerongen AV; Veerman EC
    Support Care Cancer; 2003 Apr; 11(4):226-31. PubMed ID: 12673460
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo demonstration of M3 muscarinic receptor subtype selectivity of darifenacin in mice.
    Yamada S; Maruyama S; Takagi Y; Uchida S; Oki T
    Life Sci; 2006 Dec; 80(2):127-32. PubMed ID: 16996089
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An immunohistochemistry-based study on aquaporin (AQP)-1, 3, 4, 5 and 8 in the parotid glands, submandibular glands and sublingual glands of Sjögren's syndrome mouse models chronically administered cevimeline.
    Nakamura M; Saga T; Watanabe K; Takahashi N; Tabira Y; Kusukawa J; Yamaki K
    Kurume Med J; 2013; 60(1):7-19. PubMed ID: 23925155
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A pharmacokinetic and pharmacodynamic study of intravenous pilocarpine in humans.
    Tanzer JM; Kramer PA; Schulman P; Willard AK
    J Dent Res; 1995 Dec; 74(12):1845-9. PubMed ID: 8600180
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of cevimeline on radiation-induced salivary gland dysfunction and AQP5 in submandibular gland in mice.
    Takakura K; Takaki S; Takeda I; Hanaue N; Kizu Y; Tonogi M; Yamane GY
    Bull Tokyo Dent Coll; 2007 May; 48(2):47-56. PubMed ID: 17978545
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.